Health
Why do some patients develop COVID-19 pneumonia? – Drug Target Review
Some patients who develop severe COVID-19 symptoms mount ineffective immune responses due to a lack of type I interferons.
Posted: 28 September 2020 | Hannah Balfour (Drug Target Review) | No comments yet
Scientists reveal that some patients who develop severe COVID-19 symptoms mount ineffective immune responses due to a lack of type I interferons, either through genetic mutation or inactivation by auto-reactive antibodies.
The varied severity of COVID-19 symptoms in the population has puzzled and intrigued researchers since the start of the pandemic. Now, new findings could help explain why some people with COVID…
-
General11 hours agoQantas terminal at Melbourne Airport evacuated and flights delayed due to fire
-
General24 hours ago‘Brumby Bill’ recognising heritage value of wild horses to be scrapped in NSW
-
Noosa News20 hours agoJane Edmanson hangs up her Gardening Australia hat, reflects on labour of love behind show’s success
-
General20 hours agoFrench prisoners escape jail using saw and bedsheets